Clinical Trial Update: Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome [Phase 2]

View source ↗

Summary

The Phase 2 efficacy and safety study of HU00701/HU007 Eye Drops for Dry Eye Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• HU00701/HU007 Eye Drops (HU00701)

Snippet

Sponsor: Huons Co., Ltd. | Conditions: Dry Eye Syndrome | Phase 2 | Status: COMPLETED